Regeneron

Highly Engaged Employees

Regeneron, founded in 1988 and publicly traded under NASDAQ: REGN, is a leading biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines for serious diseases. Operating within the Pharmaceuticals and Healthcare sectors, Regeneron leverages advanced science and proprietary technologies to create life-changing treatments. The company's core mission revolves around addressing unmet medical needs in areas such as cancer, eye diseases, inflammatory disorders, and rare diseases, pushing the boundaries of scientific understanding to improve patient outcomes globally. Its commitment to innovation is evident in its robust pipeline and focus on novel therapeutic approaches.

With a significant operational footprint, Regeneron employs over 10,000 individuals across its 4 locations. The company's global headquarters are situated in Tarrytown, New York, United States, serving as the central hub for its extensive research and development efforts. Learn about Regeneron's global headquarters for detailed geographic information. The dedicated workforce is instrumental in driving the company's success, contributing expertise across various scientific and operational disciplines. Meet Regeneron's team to gain insight into the talent and leadership powering its advancements in medicine.

Regeneron's product portfolio and development programs are designed to tackle complex health challenges, including treatments for cardiovascular disease and respiratory conditions, utilizing technologies like monoclonal antibodies and gene discovery. The company generated substantial revenue, reaching $14.9B in its last reported period, positioning it competitively against major industry players such as Amgen, CSL, Gilead Sciences, and AbbVie. Investors and stakeholders can Explore financial highlights for a comprehensive overview of its financial performance and market standing.